Cooperation on the Development of a Malaria Vaccine
The malaria vaccine GMZ2 to be tested in a Phase I clinical trial in Tübingen
23-Dec-2005 -
Vakzine Projekt Management GmbH (VPM) and the European Malaria Vaccine Initiative (EMVI) are cooperating in compiling and submitting the Phase I clinical trial application of malaria vaccine GMZ2 to the Paul-Ehrlich-Institute and to the Ethics Committee Tübingen, Germany. In addition, VPM shall ...
aluminium
clinical trials
Expression
+3